Thompson Davis & Co., Inc. Novo Nordisk A S Transaction History
Thompson Davis & Co., Inc.
- $132 Million
- Q3 2024
A detailed history of Thompson Davis & Co., Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Thompson Davis & Co., Inc. holds 3,530 shares of NVO stock, worth $371,779. This represents 0.32% of its overall portfolio holdings.
Number of Shares
3,530
Previous 6,280
43.79%
Holding current value
$371,779
Previous $896,000
53.13%
% of portfolio
0.32%
Previous 0.8%
Shares
4 transactions
Others Institutions Holding NVO
# of Institutions
1,948Shares Held
320MCall Options Held
5.22MPut Options Held
6.6M-
Jennison Associates LLC20.2MShares$2.13 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.51 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.51 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.4 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.29 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $238B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...